Related references
Note: Only part of the references are listed.Potent Aminocyclitol Glucocerebrosidase Inhibitors are Subnanomolar Pharmacological Chaperones for Treating Gaucher Disease
Ana Trapero et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Iminosugar-based inhibitors of glucosylceramide synthase prolong survival but paradoxically increase brain glucosylceramide levels in Niemann-Pick C mice
Jennifer B. Nietupski et al.
MOLECULAR GENETICS AND METABOLISM (2012)
Tailoring the Specificity and Reactivity of a Mechanism-Based Inactivator of Glucocerebrosidase for Potential Therapeutic Applications
Brian P. Rempel et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
The cytosolic β-glucosidase GBA3 does not influence type 1 Gaucher disease manifestation
Nick Dekker et al.
BLOOD CELLS MOLECULES AND DISEASES (2011)
Lysosomal Storage Disorders and Parkinson's Disease: Gaucher Disease and Beyond
Tamar Shachar et al.
MOVEMENT DISORDERS (2011)
Click-generated triazole ureas as ultrapotent in vivo-active serine hydrolase inhibitors
Alexander Adibekian et al.
NATURE CHEMICAL BIOLOGY (2011)
Iminosugar-Based Inhibitors of Glucosylceramide Synthase Increase Brain Glycosphingolipids and Survival in a Mouse Model of Sandhoff Disease
Karen M. Ashe et al.
PLOS ONE (2011)
Exploring the link between glucocerebrosidase mutations and parkinsonism
Wendy Westbroek et al.
TRENDS IN MOLECULAR MEDICINE (2011)
Ultrasensitive in situ visualization of active glucocerebrosidase molecules
Martin D. Witte et al.
NATURE CHEMICAL BIOLOGY (2010)
Glycosphingolipids-Nature, Function, and Pharmacological Modulation
Tom Wennekes et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations
Ozlem Goker-Alpan et al.
ARCHIVES OF NEUROLOGY (2008)
Lysosomal storage disease 1 - Phenotype, diagnosis, and treatment of Gaucher's disease
Gregory A. Grabowski
LANCET (2008)
Identification of the non-lysosomal glucosylceramidase as β-glucosidase 2
Rolf G. Boot et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Mutation of β-glucosidase 2 causes glycolipid storage disease and impaired male fertility
Yildiz Yildiz et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
X-ray structure of human acid-β-glucosidase covalently bound to conduritol-B-epoxide -: Implications for Gaucher disease.
L Premkumar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Biochemistry of glycosphingolipid storage disorders: implications for therapeutic intervention
JM Aerts et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2003)
Differential mechanism-based labeling and unequivocal activity assignment of the two active sites of intestinal lactase/phlorizin hydrolase
JCD Arribas et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Share Paper
